Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2023-05-03

Clinical Trial Update: A Feasibility Study of Octreotide Infusion During Liver Transplant. [Phase 2]

View source ↗

Summary

A Phase 2 feasibility study evaluating octreotide infusion during liver transplantation, with conditions including liver transplantation and renal failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: University College, London | Conditions: Liver Transplantation, Renal Failure | Phase 2 | Status: UNKNOWN